(Q34622270)

3 August 2017

1 reference

title

The hypothalamo-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome (English)

1 reference

3 August 2017

0 references

chronic fatigue syndrome

1 reference

Tanriverdi F

1

1 reference

3 August 2017

Karaca Z

series ordinal

2

1 reference

3 August 2017

Unluhizarci K

series ordinal

3

1 reference

3 August 2017

Kelestimur F

series ordinal

4

1 reference

3 August 2017

publication date

1 March 2007

1 reference

3 August 2017

1 reference

3 August 2017

volume

10

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

13-25

1 reference

Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

Abnormalities in response to vasopressin infusion in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

21 January 2018

Adrenal insufficiency

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

Combination therapy with hydrocortisone and fludrocortisone does not improve symptoms in chronic fatigue syndrome: a randomized, placebo-controlled, double-blind, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

Is the plasma ACTH concentration a reliable parameter in the insulin tolerance test?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

Investigation of the hypothalamo-pituitary-adrenal axis (HPA) by 1 microg ACTH test and metyrapone test in patients with primary fibromyalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

Predictors of fatigue following the onset of infectious mononucleosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

Defining the normal cortisol response to the short Synacthen test: implications for the investigation of hypothalamic-pituitary disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

Short Synacthen test versus insulin stress test for assessment of the hypothalamo [correction of hypothalmo]-pituitary--adrenal axis: controversy revisited.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

The neuroendocrinology of chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

The HPA axis and the genesis of chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

Urinary free cortisol in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

Levels of DHEA and DHEAS and responses to CRH stimulation and hydrocortisone treatment in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

The overnight single-dose metyrapone test is a simple and reliable index of the hypothalamic-pituitary-adrenal axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

A new view on hypocortisolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

Assessment of cortisol response with low-dose and high-dose ACTH in patients with chronic fatigue syndrome and healthy comparison subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

Associations between neuroendocrine responses to the Insulin Tolerance Test and patient characteristics in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

Psychoneuroendocrine effects of cognitive-behavioral stress management in a naturalistic setting--a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

Evaluation and management of endocrine dysfunction in fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

Glucagon stimulates GH secretion after intramuscular but not intravenous administration. Evidence against the assumption that glucagon per se has a GH-releasing activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

Changes in the size of adrenal glands in acute pulmonary tuberculosis with therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

Cortisol and hypothalamic-pituitary-gonadal axis hormones in follicular-phase women with fibromyalgia and chronic fatigue syndrome and effect of depressive symptoms on these hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

Hormonal responses to exercise stress test in patients with fibromyalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

Endocrine correlates of stress vulnerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

Differential responsivity of the hypothalamic-pituitary-adrenal axis to glucocorticoid negative-feedback and corticotropin releasing hormone in rats undergoing morphine withdrawal: possible mechanisms involved in facilitated and attenuated stress re

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

The 1microg short Synacthen test in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

Diurnal excretion of urinary cortisol, cortisone, and cortisol metabolites in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

A comparison between low-dose (1 microg), standard-dose (250 microg) ACTH stimulation tests and insulin tolerance test in the evaluation of hypothalamo-pituitary-adrenal axis in primary fibromyalgia syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

Regulation of corticotropin receptor number and messenger RNA in cultured human adrenocortical cells by corticotropin and angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

An audit of 500 subcutaneous glucagon stimulation tests to assess growth hormone and ACTH secretion in patients with hypothalamic-pituitary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

Hormonal responses to exercise in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

Salivary cortisol measurement in normal-weight, obese and anorexic women: comparison with plasma cortisol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

A low dose ACTH test to assess the function of the hypothalamic-pituitary-adrenal axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

Secretory pattern of GH, TSH, thyroid hormones, ACTH, cortisol, FSH, and LH in patients with fibromyalgia syndrome following systemic injection of the relevant hypothalamic-releasing hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

Blunted ACTH and cortisol responses to systemic injection of corticotropin-releasing hormone (CRH) in fibromyalgia: role of somatostatin and CRH-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

Salivary cortisol as a predictor of postoperative fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

Vasopressin stimulation of adrenocorticotropin hormone (ACTH) in humans. In vivo bioassay of corticotropin-releasing factor (CRF) which provides evidence for CRF mediation of the diurnal rhythm of ACTH

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

Blunted adrenocorticotropin and cortisol responses to corticotropin-releasing hormone stimulation in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

Desmopressin augments pituitary-adrenal responsivity to corticotropin-releasing hormone in subjects with chronic fatigue syndrome and in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

Small adrenal glands in chronic fatigue syndrome: a preliminary computer tomography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

Physiological effects of exhaustive physical exercise in primary fibromyalgia syndrome (PFS): is PFS a disorder of neuroendocrine reactivity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

Investigation of the hypothalamo-pituitary-adrenal axis and changes in the size of adrenal glands in acute brucellosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

The 'Trier Social Stress Test'--a tool for investigating psychobiological stress responses in a laboratory setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

The metabolic and hormonal response to glucagon

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10253890601130823

10.1080/10253890601130823

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference